Acorda Therapeutics Biotechnology Company | MS and Spinal Cord Injury

- acorda.com

Acorda is a biotechnology company developing and commercializing neurology therapies for Parkinson’s disease, migraine and multiple sclerosis

1,261,888 $ 960.00